SIRT1 and metabolic dysfunction-associated steatotic liver disease: These findings indicated that SIRT1 attenuated palmitate-induced ER and IR stress and the pharmacologic activation of SIRT1 may offer a potential therapeutic strategy for NAFLD management [107].